deltatrials

Denver Health and Hospital Authority Clinical Trials

Sponsors / Denver Health and Hospital Authority

The ClinicalTrials.gov registry records 74 trials led by Denver Health and Hospital Authority. Across the portfolio, 7 are in recruitment, 1 are active non-recruiting, and 57 have reached completion. 9 trials have been terminated or withdrawn. The most common reasons cited for termination include funding constraints, efficacy or futility findings. Across the portfolio, planned enrollment totals 159,859 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

74
Total Trials
7
Recruiting
1
Other Active
57
Completed
9
Terminated / Withdrawn
159,859
Total Enrollment

Termination reasons: Funding56% · Efficacy22% · Other11% · Recruitment11%

Recent Terminations

  • NCT06274359 Phase NA Stopped Mar 2025
    Influenza
    "National Institutes of Health terminated funding on March 10, 2025."
  • NCT02901067 Phase PHASE2 Stopped Aug 2021
    Venous Thromboembolism
    "COVID-19 pandemic and high proportion of patients meeting exclusion criteria."
  • NCT03615508 Phase PHASE4 Stopped May 2019
    Horner Syndrome
    "incomplete enrollment"
  • NCT01667666 Phase PHASE1 Stopped Nov 2018
    Acute Lung Injury
    "low enrollment and loss of funding"
  • NCT01838863 Phase PHASE2 Stopped Apr 2017
    Hemorrhagic Shock
    "Futility"
  • NCT02052440 Phase PHASE3 Stopped Jan 2017
    Alcohol Withdrawal Syndrome
    "Insufficient funding to complete with low enrollment rate"
  • NCT01362205 Phase PHASE4 Stopped Sep 2016
    Alcohol Withdrawal Associated Autonomic Hyperactivity
    "DSMB recommendation for slow enrollment"
  • NCT00935766 Phase PHASE3 Stopped Mar 2012
    Cardiovascular Disease
    "The study was discontinued early due to lack of funding and slow enrollment"
  • NCT00356187 Phase PHASE2 Stopped Jan 2009
    Trauma
    "Slow enrollment, end of funding"

Active Trials (1 total)

Top Conditions

Top Locations